brainy monkey, page-6

Something to talk to Warren about:

Listed in December 2005 raising AUS$13m - she is a NZ based medical technology company specialising in brain monitoring technology. The BRM2 is in use in 16 countries with an exclusive agreement with GE Healthcare for the distribution of BRM2 Brain Monitors in the UK and USA markets.

"Recent advances in neonatal medicine have dramatically improved perinatal survival rates and shifted clinical focus towards improving overall outcomes for neonates. Clinicians are particularly addressing concerns related to neurological function and brain injury, in an effort to quickly diagnose and treat the neonatal patient.

The Brainz BRM2 Brain Monitor
The BRM2 Brain Monitor is a unique and sophisticated tool for detecting changes and abnormalities in the cerebral function of neonates at the bedside. This advanced level brain monitor is designed for continuous use in the NICU environment, providing real-time neurological information 24 hours per day.

The BRM2 Brain Monitor acquires and displays information from both the right and left sides of the brain, to detect seizures or brain injury confined to a single hemisphere. This real-time, bilateral view of a patient's neurological status assists neonatal clinicians in the direction of care, while highlighting any need for neuro-imaging or clinical intervention."

http://www.brainz.com/

Current cash reserves of NZ$10.1m

Audio Broadcast - Introduction to BrainZ Instruments:

http://sa.iguana2.com/cache/d491d17263dcf9...-BZI-256047.pdf

BrainZ quarterly sales growth up 120%:

http://sa.iguana2.com/cache/7ac66bdf56cea1...-BZI-256947.pdf

GE expands BrainZ distribution:

http://sa.iguana2.com/cache/277102c292b941...-BZI-261192.pdf

Strong Growth in Monitor Sales:

http://sa.iguana2.com/cache/4138b5415babaf...-BZI-261443.pdf

BrainZ-GE deal set to spur world sales

Monday September 25, 2006
By Owen Hembry

Medical technology company BrainZ Instruments nearly doubled the sales of its brain monitor last year and a new distribution agreement should help drive the global uptake of its technology, the Auckland firm says.

BrainZ sold 74 of the monitors in the year ending August 31 - an increase of 95 per cent on the previous year - with another 19 units sold in the first two weeks of September.

The bedside units are used to monitor new-born babies' brains while in hospital.

All but one of the 19 units sold in September came through a distribution agreement with medical equipment supplier GE Healthcare, which has expanded its exclusive US and UK rights to sell BrainZ's neonatal brain monitor to 35 more territories, including Canada, parts of Europe, Middle East and North African countries.

BrainZ chief executive officer Justin Vaughan said translations in German of its products were prioritised as the first monitors were sold in that country.

"The immediate uptake by four leading hospitals is a fantastic kick-off for us," Vaughan said.

"The scale of GE allows us to roll out our technology through GE's selling channels very efficiently.

"Translated versions in French, Italian, Dutch and Spanish are also nearing completion and should follow with rapid expansion into these markets."

BrainZ would continue to sell its products direct to hospitals in New Zealand, Australia and South Africa, and would also look at expanding into Asia in 2007, he added.

The potential monitor market for newborn intensive care was about A$170 million ($193 million), paediatrics was about $40 million and adult care about $200 million with annual consumable and service sales of A$44 million, A$10 million and A$52 million respectively.

An advisory board was being assembled to help develop a plan for breaking into the adult intensive care treatment.

BrainZ monitors were already being used by Auckland's Starship Hospital in paediatrics, he added.

Meanwhile, the company was working on US Food and Drug Administration clearance for a new mathematical algorithm used to trigger an alarm in the event of a seizure. The software, which uses the algorithm, was launched in New Zealand and Australia in the last few weeks and sold for $5000 per monitor.

BrainZ, which was set up in 2001 to commercialise research from Auckland University's Liggins Institute, was bought by Tru-Test in 2002 and listed on the ASX last December. Tru-Test has retained a 57 per cent stake in the business.

http://www.nzherald.co.nz/section/story.cf...jectid=10402750

Plus:

http://www.tmcnet.com/usubmit/2006/06/08/1675763.htm

http://pharmalicensing.com/company/dc/9079

http://www.scoop.co.nz/stories/BU0606/S00142.htm

http://home.xtra.co.nz/hosts/brainzinstruments/

and:

BrainZ will be represented at the following international conferences:

Fetus & Newborn: State-Of-The-Art Care Conference in San Francisco, CA, October 25-28, 2006.

NANN 22nd Annual Educational Conference

Neonatal Nursing Excellence: Growing and Knowing November 8-11, 2006 in Nashville, TN

Furthermore, BZI is a Packer family-backed medical technology company:

Former WMC Resources chairman Hugh Morgan, his son William, Melbourne businessman John Calvert-Jones, the Packer Family's Consolidated Press International Holdings and Michael Kroger's JT Campbell & Company all grace BrainZ's share register.

Most of these early shareholders have increased their holdings since the float.

Also on the register are interests associated with computer geeks Giuseppe de Simone and Karen Synon, as well as interests associated with Christopher Stear.

Stear was one of the founding directors of Child Care Centres Australia.

At a more mature stage these types of companies do get acquired by the likes of GE and Philips (Medical Systems).